Platelets may also play a role in tumor growth following cessation of anti-angiogenic therapy; withdrawal of anti-VEGF therapies is associated with accelerated tumor growth and concurrent tumor platelet-infiltration, while platelet depletion mitigates these effects in vivo [86]. Here, VEGFA is linked to neoplasm.